Home Industry Pharmaceuticals Can New Leadership Elevate Glo...
CIO Bulletin, 19 November, 2026
Author:
Sambhrant Das
Intas Pharmaceuticals appoints veteran technology leader Praavin Chavda as Vice President of information technology, bringing over three decades of SAP, cybersecurity, and enterprise infrastructure leadership to support global operations across 85 countries.
Intas Pharmaceuticals has appointed experienced tech executive Praavin Chavda as its new Vice President of Information Technology. Chavda has over 30 years' experience and will be responsible for the delivery of IT infrastructure, cybersecurity, SAP upgrades, and governance. This is yet another step in Intas’ continued success in ensuring that its very complex formulation and distribution processes run smoothly in over 85 countries worldwide.
Enterprise Transformation Track Record Across Chemical and Industrial Sectors
Before Intas, Chavda had a number of senior technology leadership roles at a number of major chemical, manufacturing, and financial companies, leading large-scale modernization and security projects. His notable executive tenures include:
Vice President and Head of IT at Laxmi Organic Industries Ltd. (led the SAP revamp, CRM modernization, supply chain transformation and IT budgeting)
Head of Information Technology at Aarti Industries Ltd. (responsible for directing the Zero Trust security programme, the manufacturing technology environments and the software asset management programme)
Nearly 20 years at United Phosphorus Ltd as Deputy General Manager (IT), where he was responsible for the international integration of the infrastructure, CAPEX and OPEX, and the global connectivity.
Foundational Expertise in Software Development and Regional Operations
Earlier in his career, Chavda built up his engineering and operational credentials at Lloyds Finance Ltd as Senior Executive for Fixed Deposit and Software Development, having been through regional networking, infrastructure and software delivery. He started his career at Abhishek Enterprise.
At Intas Pharmaceuticals, he brings that broad operational background to bear in the areas of Enterprise Architecture, secure regulated data environments, and cross-border technology operations.
Supporting Regulated Manufacturing and International Healthcare Growth
Chavda is in the role now, and Intas Pharmaceuticals is continuing to build out its international footprint through its Accord Healthcare subsidiaries in the US, Europe, Canada, Australia, and the emerging markets. Key operational pillars supported by his technology mandate include:
17 formulations, research and manufacturing sites (including 10 in India), all of which are accredited by the international bodies (USFDA, EMA, MHRA, TGA).
Over 23,000 employees advancing therapies in oncology, CNS, cardiology, diabetology, gastroenterology, urology and animal health.
Ongoing investment in biosimilars, plasma-derived products and international commercial operations is responsible for over 70% of the company's revenue.
Digital Resilience and Governance in Multinational Life Sciences
To run globally accredited pharma facilities, an uninterrupted ERP system, robust cybersecurity, and visibility of the data are required. A seasoned leader who understands both the shop floor manufacturing systems and Zero Trust. According to CIO Bulletin, this is a major addition to the leadership team and one that will allow Intas Pharma to scale its global digital infrastructure securely and efficiently.
News Source: HR Today, https://hrtoday.in/
Everything you need to know about this news
Praavin Chavda has joined Intas Pharmaceuticals as VP – IT, with responsibility for the enterprise IT infrastructure, cybersecurity, SAP, digital transformation, and IT governance.
Prior to joining Intas Pharmaceuticals, Chavda had a number of senior IT management positions at Laxmi Organic Industries Ltd., Aarti Industries Ltd., and United Phosphorus Ltd. He had also held positions at Lloyds Finance Ltd. and Abhishek Enterprise.
He has over 30 years' experience in enterprise IT infrastructure, Zero Trust security, SAP modernization, supply chain transformation, CRM upgrades and global technology operations.
Intas operates in over 85 countries (via its Accord Healthcare subsidiaries in the US, Europe, Canada and Australia) and over 70% of its revenue is international.
The company has 17 formulation, R&D, and distribution sites, all of which are accredited by the major global health regulators (US FDA, EMA, MHRA, TGA).








Comments